Alastair Compston - Articles and news items

Genzyme logo

Genzyme receives positive CHMP opinion for LEMTRADA™ in Europe

Industry news, News / 28 June 2013 / Sanofi

“Today’s CHMP opinions set the stage for the approval of two important new treatment options…”

Genzyme logo

Genzyme announces publication of LEMTRADA (alemtuzumab) pivotal studies in The Lancet

Industry news, News / 31 October 2012 /

Significant effects of LEMTRADA™ vs. Rebif ® described in CARE-MS I and CARE-MS II publications…

Genzyme announces successful Phase III results for Alemtuzumab (LEMTRADA) in multiple sclerosis

Industry news, News / 14 November 2011 / Sanofi

The Phase lll CARE-MS ll trial met both of its co-primary endpoints…

Sanofi reports positive top-line results from first Phase 3 Study of Alemtuzumab (Lemtrada™)

Industry news / 11 July 2011 / Sanofi

Sanofi and Genzyme announced positive top-line results…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...